rs752693324
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_007347.5(AP4E1):c.3117C>T(p.Asp1039Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,612,486 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 11 hom. )
Consequence
AP4E1
NM_007347.5 synonymous
NM_007347.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.99
Publications
0 publications found
Genes affected
AP4E1 (HGNC:573): (adaptor related protein complex 4 subunit epsilon 1) This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
AP4E1 Gene-Disease associations (from GenCC):
- AP-4 deficiency syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 51Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- AP4-related intellectual disability and spastic paraplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 15-51001047-C-T is Benign according to our data. Variant chr15-51001047-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000105 (16/152216) while in subpopulation SAS AF = 0.00311 (15/4826). AF 95% confidence interval is 0.00192. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AP4E1 | ENST00000261842.10 | c.3117C>T | p.Asp1039Asp | synonymous_variant | Exon 20 of 21 | 1 | NM_007347.5 | ENSP00000261842.5 | ||
| AP4E1 | ENST00000560508.1 | c.2892C>T | p.Asp964Asp | synonymous_variant | Exon 20 of 21 | 1 | ENSP00000452976.1 | |||
| AP4E1 | ENST00000558439.5 | n.*2241C>T | non_coding_transcript_exon_variant | Exon 20 of 21 | 1 | ENSP00000452712.1 | ||||
| AP4E1 | ENST00000561393.5 | n.*2161C>T | non_coding_transcript_exon_variant | Exon 19 of 20 | 1 | ENSP00000452711.1 | ||||
| AP4E1 | ENST00000558439.5 | n.*2241C>T | 3_prime_UTR_variant | Exon 20 of 21 | 1 | ENSP00000452712.1 | ||||
| AP4E1 | ENST00000561393.5 | n.*2161C>T | 3_prime_UTR_variant | Exon 19 of 20 | 1 | ENSP00000452711.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152100Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000567 AC: 142AN: 250484 AF XY: 0.000775 show subpopulations
GnomAD2 exomes
AF:
AC:
142
AN:
250484
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000313 AC: 457AN: 1460270Hom.: 11 Cov.: 31 AF XY: 0.000450 AC XY: 327AN XY: 726504 show subpopulations
GnomAD4 exome
AF:
AC:
457
AN:
1460270
Hom.:
Cov.:
31
AF XY:
AC XY:
327
AN XY:
726504
show subpopulations
African (AFR)
AF:
AC:
1
AN:
33436
American (AMR)
AF:
AC:
0
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26112
East Asian (EAS)
AF:
AC:
3
AN:
39578
South Asian (SAS)
AF:
AC:
411
AN:
86102
European-Finnish (FIN)
AF:
AC:
0
AN:
53298
Middle Eastern (MID)
AF:
AC:
6
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
26
AN:
1110948
Other (OTH)
AF:
AC:
10
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000105 AC: 16AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
16
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41526
American (AMR)
AF:
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68018
Other (OTH)
AF:
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3474
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Oct 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Mar 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary spastic paraplegia Benign:1
Nov 18, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Stuttering, familial persistent, 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary spastic paraplegia 51 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.